Video Experimental Relacionado
Updated: Jul 24, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Reforma de la política de control de drogas para los cuidados paliativos en Rumania
Daniela Mosoiu1, Karen M Ryan, David E Joranson
1Hospice Casa Sperantei, Brasov, 500074 Romania.
Lancet (London, England)
|June 27, 2006
Resumen
Las estrictas políticas de control de drogas impiden el alivio del dolor para los pacientes con cáncer y VIH / SIDA. Rumania reformó sus leyes para mejorar el acceso a los analgésicos esenciales, un paso crucial para la salud mundial.
Área de la Ciencia:
- Salud Pública La salud pública.
- Farmacología Farmacología.
- Política de salud Política de salud
Sus antecedentes:
- El cáncer no aliviado y el dolor por VIH / SIDA es un problema de salud mundial.
- Las estrictas políticas de control de drogas limitan el acceso a los analgésicos esenciales como la morfina.
- Las regulaciones anticuadas de Rumania restringen el acceso a los opioides para los pacientes con dolor crónico.
Objetivo del estudio:
- Evaluar y recomendar cambios en las leyes y regulaciones de control de drogas de Rumania basadas en las directrices de la OMS.
- Abordar las barreras en el acceso a los analgésicos esenciales para pacientes con dolor crónico severo.
Principales métodos:
- Una comisión de cuidados paliativos del Ministerio de Salud revisó las leyes de control de drogas existentes.
- Se utilizaron las directrices de la OMS para evaluar y recomendar cambios regulatorios.
- El parlamento rumano revisó y adoptó nueva legislación.
Principales resultados:
- Rumania ha adoptado una nueva ley que simplifica los requisitos de prescripción para el tratamiento del dolor.
- La nueva ley tiene como objetivo facilitar el manejo moderno del dolor para los pacientes.
- La reforma regulatoria se identifica como clave para mejorar el alivio del dolor a nivel mundial.
Conclusiones:
- Las políticas de control de drogas reformadas son esenciales para el manejo eficaz del dolor en todo el mundo.
- Los cambios legislativos de Rumania representan un paso significativo hacia la mejora del acceso de los pacientes al alivio del dolor.
- Abordar las barreras regulatorias es crucial para las iniciativas globales de salud pública en el manejo del dolor.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:27Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications